ECLP: ECLIPSYS CORP Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 9 hrs, 4 mins

Symbol	Value	Change	Percentage Change
DJIA	11,430.21	12.78	0.11%
NASDAQ	2,380.38	-8.70	-0.36%
S&P 500	1,277.72	3.18	0.25%

ECLIPSYS CORP

ECLP

Stock price

22.70 -0.18 -0.79%

as of 04:00 PM EDT on 08/21/2008 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

22.70 0.00 0.00%

as of 05:23 PM EDT on 08/21/08

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ECLP

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2006 Employees
$477,500,000	11.7%	$41,100,000	2,220

Key Executives: ECLP

Name	Title	Officer Since
R. Andrew Eckert	CEO	11/14/05
Robert J. Colletti	CFO	-
Brian W. Copple	General Counsel	-
John P. Gomez	Executive VP	-
Danny L. Crippen	Director	6/1/04
Eugene V. Fife	Chairman of the Board/Director	5/1/97
Braden Kelly	—	-
Jay B. Pieper	Director	5/1/96

View All Key Executives

John P. Gomez has served as our Executive Vice President and Chief Technology Strategy Officer since December 2004. Mr. Gomez joined Eclipsys as Senior Vice President and Chief Technology Officer in August 2003. Prior to joining Eclipsys, Mr. Gomez served from October 2002 to January 2003 as senior vice president and chief technology officer at WebMD Corporation. Prior to that, Mr. Gomez served from February 2001 to October 2002 as Chief... View Full Profile

John P. Gomez

Dan L. Crippen has been a director of Eclipsys since June 2004. Mr. Crippen is currently self-employed as a consultant, advising medical device manufacturers, pharmaceutical companies, medical management firms, healthcare policy organizations, state and local governments, and others conducting business with the federal government. From 1999 to 2003, Mr. Crippen served as the Director of the Congressional Budget Office. From 1996 to 1999, Mr.... View Full Profile

Danny L. Crippen

Brian W. Copple has served as our Chief Legal Officer, General Counsel and Corporate Secretary since June 2005. Prior to joining Eclipsys, Mr. Copple served as Chief Legal Officer and General Counsel of Exult, Inc., a provider of human resources and related business process outsourcing services, for five years until its acquisition by Hewitt Associates. Previously, Mr. Copple was a partner with the law firm of Gibson, Dunn & Crutcher LLP.... View Full Profile

Brian W. Copple

Eugene V. Fife has been a director of Eclipsys since May 1997 and has served as Chairman of the Board since January 2003. From April 2005 to November 14, 2005, Mr. Fife served as Chief Executive Officer and President of Eclipsys on an interim basis. Since December 1999, Mr. Fife has served as the founding principal of Vawter Capital, LLC, a private investment firm. Mr. Fife was formerly a general partner in Goldman Sachs & Co., where he served as... View Full Profile

Eugene V. Fife

R. Andrew Eckert has been a director of Eclipsys, as well as Chief Executive Officer and President, since November 14, 2005. From March 2004 to October 2005, Mr. Eckert served as Chief Executive Officer of SumTotal Systems, Inc., a provider of learning and business performance technologies and services. From 2002 to March 2004, he served as Chief Executive Officer of Docent, Inc., until it merged with Click2learn to form SumTotal Systems.... View Full Profile

R. Andrew Eckert

R. Andrew Eckert has been a director of Eclipsys, as well as Chief Executive Officer and President, since November 14, 2005. From March 2004 to October 2005, Mr. Eckert served as Chief Executive Officer of SumTotal Systems, Inc., a provider of learning and business performance technologies and services. From 2002 to March 2004, he served as Chief Executive Officer of Docent, Inc., until it merged with Click2learn to form SumTotal Systems.... View Full Profile

Braden Kelly

Jay B. Pieper has been a director of Eclipsys since May 1996. Since May 1995, Mr. Pieper has served as Vice President of Corporate Development and Treasury Affairs for Partners HealthCare System, Inc., the parent of Brigham and Women"s Hospital, Inc. and Massachusetts General Hospital. He is also President of Partners International Medical Services LLC. Mr. Pieper serves on the Board of Directors of Biopure Corporation, a manufacturer of... View Full Profile

Jay B. Pieper

Robert J. Colletti has served as our Senior Vice President, Chief Financial Officer and Chief Accounting Officer since August 2001. From June to August 2001, Mr. Colletti served as our Senior Vice President Finance and Chief Accounting Officer and, from January 1997 to June 2001, as our Vice President of Finance. Mr. Colletti joined Eclipsys in January 1997 as part of our acquisition of ALLTEL Healthcare Information Services, Inc. Previously, he... View Full Profile

Robert J. Colletti

Edward A. Kangas has been a director of Eclipsys since June 2004. Mr. Kangas served as Chairman and Chief Executive Officer of Deloitte Touche Tohmatsu from 1989 to 2000. He also served as the Managing Partner of Deloitte & Touche (USA) from 1989 to 1994. He is a director of Hovnanian Enterprises Inc., a national homebuilder; Electronic Data Systems Corporation, a provider of technology and outsourcing services; Tenet Healthcare Corporation, a... View Full Profile

Edward A. Kangas

Steven A. Denning has been a director of Eclipsys since March 1997. Mr. Denning is the Chairman and a Managing Director of General Atlantic LLC, a global private equity investment firm that provides capital for innovative companies where information technology or intellectual property is a key driver of growth, and has been with General Atlantic (or its predecessor) since 1980. Mr. Denning is also a director of Genpact, a global leader in... View Full Profile

Steven A. Denning

John E. Deady joined Eclipsys in January 2006 as our Executive Vice President Client Solutions. Prior to joining Eclipsys, Mr. Deady served from October 2005 until January 2006 as Vice President and General Manager, Revenue Cycle Solutions, at McKesson Corporation, a provider of healthcare information technology. While at McKesson, Mr. Deady also served as Vice President of Marketing & Sales Support from April 2004 until October 2005. In... View Full Profile

John E. Deady

John E. Deady joined Eclipsys in January 2006 as our Executive Vice President Client Solutions. Prior to joining Eclipsys, Mr. Deady served from October 2005 until January 2006 as Vice President and General Manager, Revenue Cycle Solutions, at McKesson Corporation, a provider of healthcare information technology. While at McKesson, Mr. Deady also served as Vice President of Marketing & Sales Support from April 2004 until October 2005. In... View Full Profile

Frank E. Stearns, Jr.

John J. McAuley has served as our Senior Vice President Outsourcing since January 2007. He served as our Senior Vice President of Sales Support from April 2006 to January 2007. Prior to joining Eclipsys, Mr. McAuley served as the North America Sales Manager (December 2002 to April 2006) and Vice President and General Manager of Positron Emission Tomography (December 2000 to December 2002) at Philips Medical, a provider a global leader in... View Full Profile

John J. McAuley

Joseph C. Petro has served as our Senior Vice President Software Development since February 2007. Prior to joining Eclipsys, Mr. Petro served from 2004 as Senior Vice President, Technology, Development and Operations for TrueAdvantage, Inc., a technology enabled sales acceleration company providing software as a service solution to global sales forces. From 2002 to 2004, he was Chief Operating Officer and Delivery Officer of Intigma, an... View Full Profile

Joseph C. Petro

John T. Casey has served as the Chairman of Medcath Corporation since 2003. He joined the board of Medcath in 1999, and from 2003 to 2006 he also served as Chief Executive Officer. Medcath operates nine hospitals focused on the care and treatment of cardiovascular disease, leases mobile cardiac catheterization labs, operates fixed-site labs, conducts clinical research and provides physician practice management services to heart specialists. Prior... View Full Profile

John T. Casey

Craig Macnab has served as the Chief Executive Officer and a member of the board of directors of National Retail Properties, Inc. since 2004, and was appointed Chairman of its Board in February 2008. National Retail Properties is a publicly traded company that acquires, develops, and manages freestanding retail properties, with a portfolio of over 700 properties in 40 states. Previously, Mr. Macnab was the Chief Executive Officer and President of... View Full Profile

Craig Macnab

Top Competitors: ECLP

View Detailed Competitors Chart

Insider Trends: ECLP
Sentiment for ECLP is NEGATIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: ECLP

Date	Name	Shares	Transaction Type	Market Value
08/15/08	FIFE EUGENE V	4,000	Sale	$92,440.00
06/05/08	COPPLE BRIAN W	25,712	Sale	$541,237.60
06/05/08	COPPLE BRIAN W	24,000	Exercise of Stock Options	$326,400.00

View All Insider Activity

Ownership Breakdown : ECLP

Large Block Holder Type	Number
Institutions	161.00
Mutual Fund	266.00
Other Major	9.00

Full Details

Indices : ECLP

Symbol	Name	Last Trade	Change
$RUT.X	Russell 2000 Index	725.25	-6.35 -0.87%
$SPCY	S&P Smallcap 600 Index	—	——%

View all Indices that include ECLP

Short Interest Volume: ECLP

Data as of 7/28/08

Current Short Interest Shares	8.91 M
Current Short Interest Ratio	15.50
Float	53.65 M

Short Interest as % of Float	16.60
Average Daily Volume	762,000.00
Outstanding Shares	54.38 M

Full Details

SEC Filings: ECLP

Accepted Date	Description
08/18/2008	SEC Filing: Insider Buy/Sell
08/14/2008	SEC Filing: Insider Buy/Sell
08/14/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

ECLIPSYS CORP

ECLP

Stock price

22.70 -0.18 -0.79%

as of 04:00 PM EDT on 08/21/2008 in USD (NASDAQ Delay: 15 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ECLP

Quote Search Search the Web Search

More on Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Walletpop
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

The ECLIPSYS CORP profile at AOL Money & Finance provides you with all the eclp investing information you need. Reference AOL Money & Finance before you make your next investment!

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

ECLIPSYS CORP

ECLP

Stock price

Extended Hours

Analyst Consensus

ECLIPSYS CORP Profile

Key Executives: ECLP

Top Competitors: ECLP

Insider Trends: ECLP

Insider Transactions: ECLP

Ownership Breakdown : ECLP

Indices : ECLP

Short Interest Volume: ECLP

SEC Filings: ECLP

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials

Market Movers

Related Resources

ECLIPSYS CORP

ECLP

Stock price

Analyst Consensus

More on Money & Finance

More Stock Research